CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
91 hedge funds and large institutions have $214M invested in Concert Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
91
Holding in Top 10
1
Calls
$263K
Puts
–
Top Buyers
| 1 | +$3.79M | |
| 2 | +$2.32M | |
| 3 | +$1.83M | |
| 4 |
Millennium Management
New York
|
+$1.08M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$813K |
Top Sellers
| 1 | -$3.11M | |
| 2 | -$734K | |
| 3 | -$637K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$510K |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$431K |